GlassScriptPhysician profile
Nedal Alkhatib
NPI 1760156962
$51,494.58
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,901 · 2022: $39K · 2023: $6,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,588 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,588.44 |
| Food and Beverage | $865.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,303.06 | 2022-2023 | |
| Smith+Nephew, INC. | $13,736.93 | 2021-2023 | Microraptor, Ri Hip Navigation, R3 Acetabular |
| Djo, LLC | $5,000.00 | 2021-2022 | |
| Encore Medical, LP | $4,024.37 | 2021-2022 | |
| Legacy Ortho LLC | $2,400.00 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,480.95 | 2023 | Comprehensive Shoulder System, Juggerknotless Soft Anchor, Accufill |
| Exactech, INC. | $1,296.76 | 2022 | |
| Medical Device Business Services, INC. | $1,147.36 | 2022 | |
| Alpha Orthopedic Systems | $105.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nedal Alkhatib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.